AAAAAA

   
Results: 1-11 |
Results: 11
A PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 FOR ADVANCED OR RECURRENT NONSMALL CELL LUNG-CANCER
Authors: VOKES EE FIGLIN R HOCHSTER H LOTZE M RYBAK ME
Citation: Ee. Vokes et al., A PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 FOR ADVANCED OR RECURRENT NONSMALL CELL LUNG-CANCER, The cancer journal from Scientific American, 4(1), 1998, pp. 46-51
FMRI REVEALS AMYGDALA ACTIVATION TO HUMAN FACES IN SOCIAL PHOBICS
Authors: BIRBAUMER N GRODD W DIEDRICH O KLOSE U ERB M LOTZE M SCHNEIDER F WEISS U FLOR H
Citation: N. Birbaumer et al., FMRI REVEALS AMYGDALA ACTIVATION TO HUMAN FACES IN SOCIAL PHOBICS, NeuroReport, 9(6), 1998, pp. 1223-1226
INTERLEUKIN-2-BASED THERAPY FOR METASTATIC RENAL-CELL CANCER - THE CYTOKINE WORKING GROUP EXPERIENCE, 1989-1997
Authors: DUTCHER JP ATKINS M FISHER R WEISS G MARGOLIN K ARONSON F SOSMAN J LOTZE M GORDON M LOGAN T MIER J
Citation: Jp. Dutcher et al., INTERLEUKIN-2-BASED THERAPY FOR METASTATIC RENAL-CELL CANCER - THE CYTOKINE WORKING GROUP EXPERIENCE, 1989-1997, The cancer journal from Scientific American, 3, 1997, pp. 73-78
PROSPECTIVE RANDOMIZED TRIAL OF LISOFYLLINE FOR THE PREVENTION OF TOXICITIES OF HIGH-DOSE INTERLEUKIN-2 THERAPY IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA
Authors: MARGOLIN K ATKINS M SPARANO J SOSMAN J WEISS G LOTZE M DOROSHOW J MIER J OBOYLE K FISHER R CAMPBELL E RUBIN J FEDERIGHI D BURSTEN S
Citation: K. Margolin et al., PROSPECTIVE RANDOMIZED TRIAL OF LISOFYLLINE FOR THE PREVENTION OF TOXICITIES OF HIGH-DOSE INTERLEUKIN-2 THERAPY IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA, Clinical cancer research, 3(4), 1997, pp. 565-572
PREVALENCE OF INFECTION WITH CRYPTOSPORIDIUM-PARVUM AND CYCLOSPORA-CAYETANENSIS AMONG INTERNATIONAL TRAVELERS
Authors: JELINEK T LOTZE M EICHENLAUB S LOSCHER T NOTHDURFT HD
Citation: T. Jelinek et al., PREVALENCE OF INFECTION WITH CRYPTOSPORIDIUM-PARVUM AND CYCLOSPORA-CAYETANENSIS AMONG INTERNATIONAL TRAVELERS, Gut, 41(6), 1997, pp. 801-804
THE LITHIUM ION CONDUCTOR BETA-SPODUMENE - AN ORIENTATIONAL GLASS
Authors: BOHMER R LUNKENHEIMER P LOTZE M LOIDL A
Citation: R. Bohmer et al., THE LITHIUM ION CONDUCTOR BETA-SPODUMENE - AN ORIENTATIONAL GLASS, Zeitschrift fur Physik. B, Condensed matter, 100(4), 1996, pp. 583-593
SOLUBLE FC-GAMMA-RECEPTOR-TYPE-III (FC-GAMMA-RIII, CD16) TRIGGERS CELL ACTIVATION THROUGH INTERACTION WITH COMPLEMENT RECEPTORS
Authors: GALON J GAUCHAT JF MAZIERES N SPAGNOLI R STORKUS W LOTZE M BONNEFOY JY FRIDMAN WH SAUTES C
Citation: J. Galon et al., SOLUBLE FC-GAMMA-RECEPTOR-TYPE-III (FC-GAMMA-RIII, CD16) TRIGGERS CELL ACTIVATION THROUGH INTERACTION WITH COMPLEMENT RECEPTORS, The Journal of immunology, 157(3), 1996, pp. 1184-1192
IL-12 GENE-THERAPY USING DIRECT-INJECTION OF TUMORS WITH GENETICALLY-ENGINEERED AUTOLOGOUS FIBROBLASTS
Authors: TAHARA H LOTZE M ROBBINS PD STORKUS WJ ZITVOGEL L
Citation: H. Tahara et al., IL-12 GENE-THERAPY USING DIRECT-INJECTION OF TUMORS WITH GENETICALLY-ENGINEERED AUTOLOGOUS FIBROBLASTS, Human gene therapy, 6(12), 1995, pp. 1607-1624
IN-VIVO SELECTION OF MELANOMA VARIANTS LACKING CTL-DEFINED EPITOPES
Authors: MAEURE M CASTELLI C HURD S MARTIN D STORKUS W LOTZE M
Citation: M. Maeure et al., IN-VIVO SELECTION OF MELANOMA VARIANTS LACKING CTL-DEFINED EPITOPES, The FASEB journal, 8(4), 1994, pp. 10000209-10000209
MONOACETYLDAPSONE INHIBITION OF DAPSONE N-HYDROXYLATION BY HUMAN AND RAT-LIVER MICROSOMES
Authors: IRSHAID Y ADEDOYIN A LOTZE M BRANCH RA
Citation: Y. Irshaid et al., MONOACETYLDAPSONE INHIBITION OF DAPSONE N-HYDROXYLATION BY HUMAN AND RAT-LIVER MICROSOMES, Drug metabolism and disposition, 22(1), 1994, pp. 161-164
GLASSY, CERAMIC, AND CRYSTALLINE LITHIUM ALUMINOSILICATES - CHARGE-TRANSPORT AND LOW-TEMPERATURE SPECIFIC-HEAT STUDIES
Authors: BOHMER R LOTZE M LUNKENHEIMER P DREXLER F GERHARD G LOIDL A
Citation: R. Bohmer et al., GLASSY, CERAMIC, AND CRYSTALLINE LITHIUM ALUMINOSILICATES - CHARGE-TRANSPORT AND LOW-TEMPERATURE SPECIFIC-HEAT STUDIES, Journal of non-crystalline solids, 172, 1994, pp. 1270-1276
Risultati: 1-11 |